Literature DB >> 17904984

Characterization of a murine model of fetal programming of atherosclerosis.

Nima Goharkhay1, Elena Sbrana, Phyllis K Gamble, Esther H Tamayo, Ancizar Betancourt, Karina Villarreal, Gary D V Hankins, George R Saade, Monica Longo.   

Abstract

OBJECTIVE: The objective of the study was to investigate the effect of fetal programming on the development of atherosclerosis in the offspring in a mouse model. STUDY
DESIGN: Male and female mice of the wild type and the knockout for the apoprotein E (apoE) gene were cross-bred to obtain all 4 possible genetic offspring types. The offspring were kept on regular chow and killed at 8 months of age. Levels of total cholesterol and triglycerides were determined. The aortic arch was examined for the presence and severity of atherosclerosis. Kidney and liver sections were analyzed for pathologic changes.
RESULTS: We found increased total cholesterol levels and incidence of atherosclerosis in offspring born to hypercholesterolemic mothers as compared with genomically similar animals born to wild-type mothers. These animals also showed kidney and liver lesions consistent with chronic hypercholesterolemia.
CONCLUSIONS: There is a strong effect of fetal programming on the development of atherosclerosis in the apoE mouse model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904984     DOI: 10.1016/j.ajog.2007.08.002

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

Review 1.  Effect of maternal cardiovascular conditions and risk factors on offspring cardiovascular disease.

Authors:  Wulf Palinski
Journal:  Circulation       Date:  2014-05-20       Impact factor: 29.690

2.  Inheritance pattern of familial hypercholesterolemia and markers of cardiovascular risk.

Authors:  D Meeike Kusters; Hans J Avis; Marjet J Braamskamp; Roeland Huijgen; Frits A Wijburg; John J Kastelein; Albert Wiegman; Barbara A Hutten
Journal:  J Lipid Res       Date:  2013-07-05       Impact factor: 5.922

3.  Maternal exposure to soy diet reduces atheroma in hyperlipidemic F1 offspring mice by promoting macrophage and T cell anti-inflammatory responses.

Authors:  Ramona L Burris; Sarah C Vick; Branimir Popovic; Pamelia E Fraungruber; Shanmugam Nagarajan
Journal:  Atherosclerosis       Date:  2020-09-22       Impact factor: 5.162

Review 4.  Developmental mechanisms involved in the primary prevention of atherosclerosis and cardiovascular disease.

Authors:  Claudio Napoli
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

5.  Effect of gestational hypercholesterolemia and maternal immunization on offspring plasma eicosanoids.

Authors:  Oswald Quehenberger; Tomoya Yamashita; Aaron M Armando; Edward A Dennis; Wulf Palinski
Journal:  Am J Obstet Gynecol       Date:  2011-03-26       Impact factor: 8.661

6.  Maternal Phytosterol Supplementation during Pregnancy and Lactation Modulates Lipid and Lipoprotein Response in Offspring of apoE-Deficient Mice.

Authors:  Todd C Rideout; Cheryl Movsesian; Yi-Ting Tsai; Aadil Iqbal; Amy Raslawsky; Mulchand S Patel
Journal:  J Nutr       Date:  2015-06-17       Impact factor: 4.798

7.  Evidence of maternal QTL affecting growth and obesity in adult mice.

Authors:  Joaquim Casellas; Charles R Farber; Rodrigo J Gularte; Kari A Haus; Craig H Warden; Juan F Medrano
Journal:  Mamm Genome       Date:  2009-04-28       Impact factor: 2.957

Review 8.  Influence of maternal dysmetabolic conditions during pregnancy on cardiovascular disease.

Authors:  Wulf Palinski; Eric Nicolaides; Antonio Liguori; Claudio Napoli
Journal:  J Cardiovasc Transl Res       Date:  2009-05-29       Impact factor: 4.132

9.  Maternal hypercholesterolemia leads to activation of endogenous cholesterol synthesis in the offspring.

Authors:  Nima Goharkhay; Esther H Tamayo; Huaizhi Yin; Gary D V Hankins; George R Saade; Monica Longo
Journal:  Am J Obstet Gynecol       Date:  2008-09       Impact factor: 8.661

Review 10.  Excessive early-life cholesterol exposure may have later-life consequences for nonalcoholic fatty liver disease.

Authors:  Jerad H Dumolt; Mulchand S Patel; Todd C Rideout
Journal:  J Dev Orig Health Dis       Date:  2020-04-15       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.